17 Dec 2016
Aurobindo shares hit 9-month low on US price fixing lawsuit
Welcome to Indian Share Market
Serving Since 2007
Custom Search
Learn and then Earn
Earning money in share maket  requires appropriate knowledge and experience, so it is highly advisable to gain adequate knowledge before start trading and investing in share market.
The information provided on this website is for educational purpose and not to be considered as investing or trading advice.
The investment and trading has to be done on sole discretion and www.daytradingshares.com or any person related to this site Should not be held responsible for the outcome.
Copyright © 2007-2016, www.daytradingshares.com. All Rights Reserved.
Drugmaker Aurobindo Pharma Ltd's shares hit their lowest in more than nine months on Friday after it was named in a lawsuit alleging it colluded with other drugmakers to fix prices of two commonly-used drugs in the United States.
About 44 per cent of Aurobindo's sales come from its US business.

The lawsuit, filed in the US District Court for the District of Connecticut by 20 US states, also named Heritage Pharmaceuticals Inc, a company owned by India's Emcure Pharma Ltd, as a "ring leader" of the price manipulation.
The suit pertained to commonly-used antibiotic doxycycline hyclate, and glyburide, an older drug used to treat diabetes.

A spokeswoman for Hyderabad-based Aurobindo did not respond to a request for comment on Friday.

Others named in the suit include the world's largest generic drugs maker Teva Pharmaceuticals, Mylan NV, Citron Pharma LLC, and Australia's Mayne Pharma.
The suit comes after months of increasing scrutiny over generic drug prices in the United States, the world's largest healthcare market. Drug pricing probes are ongoing at both the state and federal level in the country.

Two of India's largest drugmakers - Sun Pharmaceutical Industries Ltd and Dr Reddy's Laboratories Ltd - have previously disclosed having received subpoenas under a US Department of Justice investigation into drug price rises by generic drugmakers.

Shares in Sun Pharma were down over 1 per cent and those in Dr Reddy's were trading flat at 11:49 am on Friday.

Aurobindo, Sun Pharma and Dr Reddy's are having best fundamentals and have provided excellent returns in past and will provide best returns in future as well.

One of the investing principles is to buy shares of strong fundamental companies in bad times.